Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
MONK v. JOHNSON & JOHNSON et al
Case Number:
3:10-cv-04841
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
-
October 25, 2013
Investors Rip Fee Request By Carella Byrne, Kessler Topaz
Investors objected Thursday to an attorneys' fees request that would give two firms — Carella Byrne Cecchi Olstein Brody & Agnello PC and Kessler Topaz Meltzer & Check LLP — 20 percent of a $23 million settlement with Johnson & Johnson, calling the payout "neither modest nor reasonable."
-
July 16, 2013
J&J To Pay $23M To Settle Investors' Drug Recall Suit
Johnson & Johnson will pay $23 million to settle a shareholder class action alleging that the company failed to disclose manufacturing violations leading to the biggest recall of over-the-counter children's medicine in U.S. history, according to a Monday filing in New Jersey federal court.
-
May 22, 2012
Judge Won't Reconsider CEO Liability For J&J Recalls
A New Jersey federal judge on Tuesday refused the request of Johnson & Johnson shareholders to reconsider her December decision that CEO William Weldon could not be held liable for several costly drug recalls as part of a securities suit.
-
January 04, 2012
J&J Investors Renew Push For CEO Liability In Recalls
A putative class of Johnson & Johnson shareholders on Tuesday lambasted a New Jersey federal judge's interpretation of a key provision of securities law as they sought to hold the company's CEO liable for several costly recalls of Tylenol and other medications.
-
December 19, 2011
Judge Trims J&J Investor Suit Over Kids' Meds Recalls
A New Jersey federal judge on Monday pared a putative shareholder class action accusing Johnson & Johnson of failing to disclose manufacturing violations that led to several recalls of popular children's medications and caused the health care company's stock to tank.